- Exchange: New York
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Valeant Pharmaceuticals International Inc+ Add to Watchlist
VRX:US237.5300 USD 4.2600 1.83%
As of 20:04:04 ET on 05/22/2015.
Company Profile for Valeant Pharmaceuticals International Inc (VRX)
Valeant Pharmaceuticals International, Inc. develops and distributes drugs. The Company develops drugs for unmet medical needs in central nervous system disorders, and distributes generic and branded generic drugs in Latin America and Eastern Europe.
Valeant Pharmaceuticals International Inc
Key Executives for Valeant Pharmaceuticals International Inc (VRX)
|J Michael Pearson "Mike"Chairman/CEO||Ari S KellenGroup Chairman/Exec VP|
|Laizer D KornwasserGroup Chairman/Exec VP||Anne C WhitakerGroup Chairman/Exec VP|
|Pavel MirovskyPresident/Gen Mgr:Europe||Howard B SchillerExec VP/CFO|
|Robert R Chai-OnnExec VP/Chief Legal Ofcr/Gen Cnsl||Brian M StolzExec VP:Administration|
|Linda A LagorgaSenior VP/Treasurer||Laurie W LittleSenior VP:Investor Relations|